Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) FDC
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) FDC, covering 2018-09-14 to 2018-09-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed Dose Combination (FDC) Versus a Regimen Consisting of Darunavir/Cobicistat FDC With Emtricitabine/Tenofovir Disoproxil Fumarate FDC in Treatment-naive HIV Type 1 Infected Subjects [Phase 3]